| The importance of glycated haemoglobin (HbA(1c)) and postprandial glucose (PPG) control on cardiovascular outcomes in patients with type 2 diabetes. | |
| | |
MedLine Citation:
|
PMID: 20494468 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Vascular complications are the leading cause of morbidity and mortality in type 2 diabetes. Cardiovascular disease is significantly more common in patients with type 2 diabetes than in non-diabetics, and accounts for more than two-thirds of deaths associated with the condition. Many physicians believe that hyperglycaemia is responsible, at least in part, for this additional risk. The benefit of improved glycaemic control on microvascular complications is well established and recent trials have attempted to clarify the role of glycaemic control on macrovascular outcomes. This article reviews the recent evidence from a post-interventional analysis of the UKPDS and the ACCORD, ADVANCE, VADT and HEART2D trials for an association between elevated blood glucose levels and vascular complications. The data suggest that improved glycaemic control has the potential to significantly reduce the risk of micro- and macrovascular disease when instigated early in the disease course. However, in more advanced diabetes, the benefits of improved control appear to be less evident. Recent studies have also suggested that controlling postprandial glucose may be an important component in the reduction of vascular complications. Taken together, these studies indicate that glycaemic control remains a key cornerstone in the management of type 2 diabetes. |
| | |
Authors:
|
Pan Chang Yu; Zsolt Bosnyak; Antonio Ceriello |
Related Documents
:
|
14598868 - Haemoglobin a1c--a marker for complications of type 2 diabetes: the experience from the... 16567538 - Endothelial glycocalyx damage coincides with microalbuminuria in type 1 diabetes. 18220638 - Therapeutic management strategies for type 2 diabetes. 22462028 - The diabetic heart: too sweet for its own good? 12453918 - Interleukin-1 receptor antagonist genotype is associated with coronary atherosclerosis ... 15644818 - Persistent hyperglycemia in critically ill children. |
Publication Detail:
|
Type: Journal Article; Review Date: 2010-05-21 |
Journal Detail:
|
Title: Diabetes research and clinical practice Volume: 89 ISSN: 1872-8227 ISO Abbreviation: Diabetes Res. Clin. Pract. Publication Date: 2010 Jul |
Date Detail:
|
Created Date: 2010-06-28 Completed Date: 2010-09-29 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8508335 Medline TA: Diabetes Res Clin Pract Country: Ireland |
Other Details:
|
Languages: eng Pagination: 1-9 Citation Subset: IM |
Affiliation:
|
Department of Endocrinology, Chinese PLA General Hospital, Beijing, China. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Blood Glucose
/
drug effects,
metabolism Cardiovascular Diseases / epidemiology*, metabolism, prevention & control Diabetes Mellitus, Type 2 / drug therapy, epidemiology*, metabolism Hemoglobin A, Glycosylated / metabolism* Humans Hyperglycemia / drug therapy, epidemiology*, metabolism Hypoglycemic Agents / therapeutic use Incidence Risk Factors |
| Chemical | |
Reg. No./Substance:
|
0/Blood Glucose; 0/Hemoglobin A, Glycosylated; 0/Hypoglycemic Agents; 0/hemoglobin A1c protein, human |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Toxic exposure in America: Estimating fetal and infant health outcomes from 14 years of TRI reportin...
Next Document: MARS: The ultimate warrior against pruritus of cholestasis?